Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human galactocerebrosidase

EU orphan designation number: EU/3/11/911   
Active ingredient: Recombinant human galactocerebrosidase
Indication: Treatment of globoid cell leukodystrophy (Krabbe disease)
Sponsor: ACE BioSciences A/S
Roskildevej 12C, 3400 Hillerød, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Orphan designation EMA/OD/042/11 (2011)7044 of 27/09/2011